BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38567425)

  • 1. SKF82958, a dopamine D1 receptor agonist, disrupts prepulse inhibition in the medial prefrontal cortex and nucleus accumbens in C57BL/6J mice.
    Yang C; Chen X; Xu J; Chen W
    Behav Pharmacol; 2024 Jun; 35(4):193-200. PubMed ID: 38567425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.
    Wakabayashi C; Numakawa T; Ooshima Y; Hattori K; Kunugi H
    Psychopharmacology (Berl); 2015 Dec; 232(24):4393-400. PubMed ID: 26359228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pimavanserin, a 5-hydroxytryptamine 2A receptor inverse agonist, reverses prepulse inhibition deficits in the nucleus accumbens and ventral hippocampus.
    Shi M; Tang J; Yang C; Guo G; Ou H; Chen W
    Neuropharmacology; 2021 Dec; 201():108838. PubMed ID: 34666074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
    Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
    Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation.
    Swerdlow NR; Shoemaker JM; Kuczenski R; Bongiovanni MJ; Neary AC; Tochen LS; Saint Marie RL
    Neurosci Lett; 2006 Jul; 402(1-2):40-5. PubMed ID: 16644125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prefrontal allopregnanolone synergizes with D
    Frau R; Traccis F; Concas L; Cadeddu R; Mosher LJ; Nordkild P; Gaikwad NW; Bortolato M
    Psychopharmacology (Berl); 2023 Jun; 240(6):1359-1372. PubMed ID: 37129616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice.
    Ralph-Williams RJ; Lehmann-Masten V; Otero-Corchon V; Low MJ; Geyer MA
    J Neurosci; 2002 Nov; 22(21):9604-11. PubMed ID: 12417685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal D1 and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats.
    Shoemaker JM; Saint Marie RL; Bongiovanni MJ; Neary AC; Tochen LS; Swerdlow NR
    Neuroscience; 2005; 135(2):385-94. PubMed ID: 16125865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCB-2, a 5-hydroxytryptamine 2A receptor agonist, disrupts prepulse inhibition in the ventral pallidum and nucleus accumbens.
    Ou H; Tang J; Guo G; Shi M; Yang C; Chen W
    Behav Brain Res; 2023 Feb; 437():114127. PubMed ID: 36174843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
    Cools AR; Lubbers L; van Oosten RV; Andringa G
    Neuropharmacology; 2002 Feb; 42(2):237-45. PubMed ID: 11804620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dorsal striatum D1-expressing neurons are involved with sensorimotor gating on prepulse inhibition test.
    Rodrigues S; Salum C; Ferreira TL
    J Psychopharmacol; 2017 Apr; 31(4):505-513. PubMed ID: 28114835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK212, a 5-hydroxytryptamine 2C receptor agonist, reverses prepulse inhibition deficits in the medial prefrontal cortex and ventral hippocampus.
    Guo G; Tang J; Shi M; Yang C; Ou H; Chen W
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110441. PubMed ID: 34560172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basolateral amygdala modulation of the nucleus accumbens dopamine response to stress: role of the medial prefrontal cortex.
    Stevenson CW; Gratton A
    Eur J Neurosci; 2003 Mar; 17(6):1287-95. PubMed ID: 12670317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline prepulse inhibition expression predicts the propensity of developing sensitization to the motor stimulant effects of amphetamine in C57BL/6 mice.
    Peleg-Raibstein D; Hauser J; Llano Lopez LH; Feldon J; Gargiulo PA; Yee BK
    Psychopharmacology (Berl); 2013 Jan; 225(2):341-52. PubMed ID: 22899220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.
    Gresack JE; Seymour PA; Schmidt CJ; Risbrough VB
    Psychopharmacology (Berl); 2014 May; 231(10):2189-97. PubMed ID: 24363077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consolidation of object recognition memory requires simultaneous activation of dopamine D1/D5 receptors in the amygdala and medial prefrontal cortex but not in the hippocampus.
    Rossato JI; Radiske A; Kohler CA; Gonzalez C; Bevilaqua LR; Medina JH; Cammarota M
    Neurobiol Learn Mem; 2013 Nov; 106():66-70. PubMed ID: 23891712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats.
    Mosher LJ; Frau R; Pardu A; Pes R; Devoto P; Bortolato M
    Br J Pharmacol; 2016 Jul; 173(13):2122-34. PubMed ID: 26101934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.
    Scornaiencki R; Cantrup R; Rushlow WJ; Rajakumar N
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1195-208. PubMed ID: 19275776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.